MINOCYCLINE HYDROCHLORIDE
| Brand name | SOLODYN |
|---|---|
| Active ingredient | MINOCYCLINE HYDROCHLORIDE |
| Strength | EQ 135MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | May 2006 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 7919483 | March 2027 | use U-1078 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.